Join IAG’s Bio Partnering Team at UEGW – Vienna – 2022
IAG’s Bio-Partnering team will be attending United European Gastroenterology Week 2022 (UEGW 2022) , 8-11 October 2022.
IAG’s partnering team are focused on building a diversified portfolio of innovative life science companies at various stages of clinical development.
IAG’s current portfolio consists of biotech, pharma and digital health companies.
By bringing strategic collaborators and smart investments, we support novel drug or technology development efforts through conceptualisation, clinical trials to market entry.
Our portfolio companies take full advantage of a wide range of IAG’s innovative R&D solutions, operational breadth and expertise, risk-sharing financing and partnership models.
We directly invest or provide in-kind support to biotech and pharma companies, with potential licenced pharmaceutical products, addressing unmet patient needs in gastroenterology, immune-oncology, oncology, inflammation, rheumatology, musculoskeletal, rare diseases, neuro-degenerative and immunology markets.
More on our recent partnerships can be found here: https://www.ia-grp.com/trial-solutions/bio-partnering/
About Image Analysis Group (IAG)
IAG, Image Analysis Group is a unique partner to life sciences companies. IAG leverages expertise in medical imaging and the power of Dynamika™ – our proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner. IAG provides early drug efficacy assessments, smart patient recruitment and predictive analysis of advanced treatment manifestations, thus lowering investment risk and accelerating study outcomes. IAG bio-partnering takes a broader view on asset development bringing R&D solutions, operational breadth, radiological expertise via risk-sharing financing and partnering models.
Learn more: www.ia-grp.com
Reach out: firstname.lastname@example.org
Follow the Company: Linkedin